This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
What could the implications be for patients on their medical cannabis journey? Rescheduling would ease those research barriers, improving access to data and education around the plant and opening the door to fully explore the medical benefits cannabis could provide. What does rescheduling cannabis mean for medical cannabis patients?
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”
The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”
Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One.
The Changing Landscape of Me dical Marijuana in Massachusetts: What Patients Should Know The Massachusetts medical marijuana program has been a cornerstone of cannabis access since its inception in 2012. MPAA) the states leading voice for patient rights and cannabis policy reform. decrease from peak enrollment.
The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. In addition, IDPH worked toward the establishment of a new patient tracking system and staff were trained on its functions and capabilities. Refresh QA plans with a focus on staffing assignments.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
Preliminary data*, released on request from the Pennsylvania State Police Uniform Crime Reporting System, reveals that overall arrests for marijuana possession showed a decline in 2019. The new data shows 19,990 adults arrested for the same offense in 2019. cannabis arrest data since 2008. cannabis arrest data since 2008.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. This growth has allowed for the creation of new jobs, increased access to cannabis for consumers, and shows the State’s commitment to social equity in its cannabis programs.”
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
Patients purchased an estimated $112 million worth of medical cannabis-related products in 2019, according to newly released Maine tax data. million) came from sales by caregivers to patients. Only the state’s lobster industry and potato industry bring in more annual revenue.
The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”
physicians “from completing forms or registering veterans for participation in state-approved [medical marijuana] program[s].” For example, a 2014 study reported a 75 percent reduction in PTSD symptomology scores following subjects’ enrollment in a state-sponsored medical cannabis access program.
Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. So, it shouldn’t be a huge surprise that Virginia didn’t launch a medical marijuana program until 2015, nearly two decades after California.
Recently released data from the ACLU shows that despite similar usage rates, black Americans were nearly 4 times more likely to be arrested for a marijuana crime than whites. These services are especially crucial for vulnerable medical marijuana patients. You can read NORML’s factsheet on the racial disparity among arrests here.
Also introduced was The Marijuana Data Collection Act of 2019 , which would study the effects of state legalized medicinal and non-medicinal marijuana programs from a variety of perspectives, including state revenues, public health, substance abuse and opioids, criminal justice, and employment.
Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs.
Starting this week, the Cannabis Control Commission (Commission)’s Open Data Platform composed of application and license, agent registration and ownership, and sales and product distribution information is now available on their main website at. MassCannabisControl.com/open- data. View the Open Data Platform.
million patients in 2022, a sharp increase from the 3.1 This data aligns with Americans’ rising acceptance of cannabis. While there have been some drops in medical patient registration in states with adult-use (recreational) programs, pandemic-era programs also directly attributed to part of the increase in patient registration.
16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access. The Missouri Department of Health and Senior Services (DHSS) issued 56,448 new patient licenses and 12,062 renewed patient licenses between Dec. Psychiatric disorders accounted for 11,914 patients.
New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).
Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. billion, servicing nearly 340,000 active patients. In 2019, the island’s economy grew by 2.1% in real terms to £4.97 to reach 3.2 to reach 3.2
– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. Declining circulating tumor cell (CTC) count in treated patients.
For those communities that have been economically and socially disenfranchised by overcriminalization and cyclical incarceration, this legislation provides funding to programs focused on youth development, citizen re-entry, job training, health education, and funding for community resources such as public libraries and community centers.
In a newly published survey of 162 IBD patients in Puerto Rico, where medical cannabis is legal but recreational use is punishable with prison time , about 25% anonymously reported using cannabis to treat their symptoms. Findings from another recent survey of New York and Minnesota medical cannabis dispensary patients were similar.
16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. The program will be offered for free to Québec physicians and is made possible by an unrestricted educational grant from Spectrum Therapeutics.
Patients around the world are in need of natural, alternative medical solutions, and Realm of Caring (RoC) is on a mission to serve them. RoC also works to increase patients’ access to medical cannabis by helping U.S. To date, Veriheal’s global team has helped hundreds of thousands of patients gain access to medical cannabis. “The
Akerna Connect is an eCommerce software which provides a suite of digital marketing tools to retailers and dispensaries so locations can reach their consumers and enhance the shopping experience through online ordering, loyalty programs, and text messaging. In addition, consumers can opt-in for loyalty programs and text message alerts.
No data exists on how many registered medical patients are actively growing cannabis in Illinois. Though many reasons factor into the number of patients who grow and why, two trendlines that are heading in opposite direction may suggest more medical cannabis patients in Illinois are opting to grow their own medicine.
Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.
But in addition to the 18 states with legal adult-use (as well as medical), there are another 18 states that have fully functioning medical marijuana programs. In these three dozen states, from the West Coast to the Midwest to the South and the Northeast, patients use cannabis to treat countless medical conditions and everyday ailments.
A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. The newsroom specifically requested aggregate data — information that would not identify individual patients.
In the 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), the Department of Financial & Professional Regulation (IDFPR) states in its data summary, “Looking ahead to Fiscal Year 2025, IDFPR has already begun its efforts to further expand access to cannabis both to consumers and medical patients.
The bill, now signed into law, includes numerous patient-focused updates to the Pennsylvania Medical Marijuana Program , the majority of which became effective immediately upon the Governor’s signing. of House members.
South Dakota started approving medical cannabis patient and physician applications but at a rate that could make it difficult for patients to connect with doctors registered for the program. Health officials have also denied 45 applications by physicians seeking to participate in the program. Full report.
A pair of boxing legends teamed up for an unexpected collaboration, Texas’ medical cannabis program saw big gains, and a hemp study revealed troubling signs for the industry. Texas’ Medical Cannabis Program Sees Growth Despite Limitations. Further, the state only has three dispensing organizations to serve its growing program.
Metrc stated, “Seamless data tracking in Metrc helps operators optimize inventory control, accurately report sales data, and improve cultivation management. To qualify and receive a medical patient card at a discounted rate, visit here. Illinois uses BioTrack as its current track-and-trace vendor.
Unlike most other ailments, there isn’t a simple test that physicians can use to diagnose a patient with a disorder. CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. (CSE: Source: Data Bridge.
The successes of cannabis businesses are now a part of the mainstream conversation and considered big business, while the rights and protections for medical cannabis patients have been sidelined. So while a cannabis business can join their local chamber of commerce, a patient in hospice can be denied access to medical cannabis.
Quemarr Moatamedi School: University of Montana Major/Program: Linguistics and Anthropology Innovation: Emulsion-Based Edibles: Harnessing Anti-Diabetic Cannabinoids in Diabetes Management. Quemarr’s transformative approach to diabetes treatment offers patients a less intrusive alternative to conventional insulin treatments.
The Israeli government formally legalized medical marijuana in 1999, and by 2020 the number of registered patients reached a record high of over 70,000. Also in 2020, Israel surpassed Germany as the world’s largest importer of medical cannabis flower, according to data from Israel’s online Cannabis Magazine.
For an engineer like Rick, who understood the value of evidence and data, it was a revelation. Most patients say it tastes terrible – imagine the most bitter, plant-like flavor you can think of, and you’re getting close. Not just for Rick, but for all the patients who depended on him? And he never turned anyone away.
The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content